Prevention of Future Deaths reports · 2014
Regulation 28 report to prevent future deaths, reference 2014-0479, written 3 Nov 2014. A coroner writes one of these when an inquest reveals a risk that could cause further deaths unless something changes.
| Date of report | 3 Nov 2014 |
|---|---|
| Reference | 2014-0479 |
| Deceased | Sandra Higham |
| Coroner | Henrietta Hill |
| Coroner area | London Inner (South) |
| Category | Hospital Death (Clinical Procedures and medical management) related deaths |
| Source | judiciary.uk record · original PDF |
| Responses published | 3 |
Text recovered by OCR from a scanned PDF. OCR is imperfect: check anything you rely on against the source PDF. Reproduced verbatim, including the scan's own layout.
REGULATION 28: REPORT TO PREVENT FUTURE DEATHS REGULATION 28 REPORT TO PREVENT FUTURE DEATHS THIS REPORT IS BEING SENT TO: 1. The Heart Rhythm Society of the United Kingdom 2. Public Health England 3. The Secretary of State for Health, Department of Health 1 | CORONER lam HENRIETTA HILL, assistant coroner, for the coroner area of Inner South District of Greater London. 2 | CORONER’S LEGAL POWERS | make this report under paragraph 7, Schedule 5, of the Coroners and Justice Act 2009 and regulations 28 and 29 of the Coroners (Investigations) Regulations 2013. 3 | INVESTIGATION and INQUEST On 12 December 201 an investigation into the death of SANDRA HAZEL ELIZABETH HIGHAM, then aged 65 years, was opened by deputy coroner Lorna Tagliavini. On 10 June 2014 an inquest into Ms Higham’s death was opened by assistant coroner Sarah Ormonde-Walsh. The inquest was adjourned. The inquest into Ms Higham’s death was resumed, and concluded, by myself on 17 October 2014. The medical cause of Ms Higham’s death was cerebral ischaemia, caused by atrial- oesophageal fistula, caused by ablation for atrial fibrillation. The conclusion of the inquest was a narrative conclusion, as follows: (1) Ms. Higham died at St. Thomas's Hospital, London on 7 December 2013. (2) She had undergone an ablation procedure to her heart on 17 October 2013 and this had caused an atrial-oesophageal fistula to develop. (3) This led to her suffering neurological, fever and vomiting symptoms for which she was admitted to Tunbridge Wells Hospital on 23 November 2013. A fistula of this nature is a very rare, but known, risk of the ablation procedure. (4) She was transferred to St. Thomas’. Hospital, London on 24 November 2013 when two attempts were made to ‘stent’ her heart, but she died from the neurological consequences of the fistula, on 7 December 2013. 4 | CIRCUMSTANCES OF THE DEATH The circumstances of the death are reflected in the narrative above. 5 | CORONER’S CONCERNS During the course of the inquest the evidence revealed matters giving rise to concern. In my opinion there is a risk that future deaths will occur unless action is taken. In the circumstances it is my statutory duty to report to you. The MATTERS OF CONCERN are as follows. — (1) The ablation procedure, as a method of addressing atrial fibrillation, is becoming more widespread (an increase of around 20-30% in recent years). (2) The development of an atrial-oesophageal fistula is a very rare, but known, risk of the ablation procedure (developing in around 0.01-0.2% of cases of percutaneous ablation and around 1-1.5% of cases of surgical ablation). (3) If an atrial-oesophageal fistula does develop, it has a very high mortality rate (reported to be 67-100%). (4) According to the literature there are no clear predictors of mortality from an atrial-oesophageal fistula, but early diagnosis, prompt surgical intervention and prolonged antibiotic therapy may be crucial for survival. (5) Diagnosing an atrial-oesophageal fistula can be difficult, especially in an acute medical setting, given its range of non-specific symptoms and duration of onset, and the lack of awareness within the wider medical profession of such a fistula being a risk of the ablation procedure. ACTION SHOULD BE TAKEN in my opinion action should be taken to prevent future deaths and | believe your organisation has the power to take such action. YOUR RESPONSE You are under a duty to respond to this report within 56 days of the date of this report, namely by 29 December 2014. I, the coroner, may extend the period. Your response must contain details of action taken or proposed to be taken, setting out the timetable for action. Otherwise you must explain why no action is proposed. COPIES and PUBLICATION | have sent a copy of my report to the Chief Coroner and to the following Interested Persons: the family ofMs Higham, Maidstone and Tunbridge Wells NHS Trust and | am also under a duty to send the Chief Coroner a copy of your response. The Chief Coroner may publish either or both in a complete or redacted or summary form. He may send a copy of this report to any person who he believes may find it useful or of interest. You may make representations to me, the coroner, at the time of your response, about the release or the publication of your response by the Chief Coroner. 3 November 2014 Signed ..\AL? UMmahflW sees ‘Assistant Coroner
3 responses published against this report on judiciary.uk. A response is a body's written reply to the coroner's concerns; publication is at the discretion of the Chief Coroner's office, so an absent response does not mean nobody replied.
BHRS British Heart Rhythm Society PO Box 3697 Stratford upon Avon CV37 8YL 19" December 2014 Ms Henrietta Hill Assistant Coroner Inner South London Coroner’s Court 1 Tennis Court London SE1 1YD Dear Ms Hill REPORT ON DEVELOPMENT OF ATRIO-OESOPHAGEAL FISTULA FOLLOWING ABLATION FOR ATRIAL FIBRILLATION Ablation as a therapeutic option for the management of atrial fibrillation (AF) is an increasingly common procedure undertaken for patients with significant symptoms secondary to this arrhythmia. In the UK, some 6,000 catheter based ablation procedures were undertaken for AF from April 2013 to March 2014. There are recognised risks associated with this procedure: recent reported evidence shows that atrio-oesophageal fistula occurs in 0.04% of patients,! although this is likely to be an underestimate and the actual incidence is probably between 0.1 and 0.2%. This complication always presents sometime after the procedure, Other complications, such as pulmonary vein stenosis or Dressler’s syndrome will also have a delay to presentation. The British Heart Rhythm Society (BHRS) is of the opinion that there are two areas that can be looked at to help reduce this complication. Procedural considerations include an awareness of the risk of this complication, reduction / titration and location of energy delivered. However, there is no evidence that newer ablation technologies or other strategies such as oesophageal temperature monitoring, make a significant difference to the occurrence of this complication. Operators should be aware that they need to limit the amount of ablation that takes place to the posterior wall of the left atrium and be aware of the possibility of this complication. BHRS believes that colleagues who perform this procedure are aware of this complication and take appropriate steps to reduce the likelihood of its occurrence. i Cappato R, Calkins H, Chen SA, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Cire Arrhythm Electrophysiol 2010; 3: 32-8. -1- The second area is patient education and this is likely to be of more benefit. Patients can be made more aware of this complication and also warning signs such as fever, epigastric pain, headache etc. They need to be told in this situation to (a) go to their local emergency department immediately and (b) they should contact the centre where the ablation was performed. We feel we should work with our sister organisations, the AF Association and the Arrhythmia Alliance (A-A) both of which are patient orientated organisations to improve the information and education patients are given; the information leaflets and on line information produced by these organisations will be amended to reflect this. We will work to develop a leaflet which can be downloaded from these sites. Patients could be issued with this on discharge following their AF ablation, giving information as to what symptoms to be aware of and advice to medical teams as to how to investigate and manage this complication, together with contact details for the ablation centre. PROPOSED ACTIONS e BHRS will include an article on avoidance and recognition of atrio-oespohageal fistula in its winter newsletter which is circulated to all BHRS members in January and remind its members to ensure this complication is recorded in the national cardiac rhythm management database for which BHRS and the National Institute for Cardiovascular Research (NICOR) are responsible. e BHRS will work with the AF Association and A-A to re-design the patient information relating to complications of AF ablation to include information on recognition of symptoms associated with the complication. As part of this, a leaflet will be developed, as detailed above, which will be able to be downloaded from the AF Association, A-A and BHRS websites to be given to patients on discharge following their AF ablation. This should be able to be completed by the end of March 2015. Yours sincerely President, British Heart Rhythm Society
From Dr Dan Poulter MP Parliamentary Under Secretary of State for Health Department Richmond House of Health aaa POCS 898876 SWIA 2NS Tel: 020 7210 4850 Ms H Hill Assistant Coroner Southwark Coroner’s Court 1 Tennis Street Southwark 17 MAR 2015 SE1 1YD Thank you for your letter following the inquest into the death of Sandra Higham. In your report you state that Ms Higham died from cerebral ischaemia as the result of an atrial-oesophageal fistula which developed following an ablation procedure for atrial fibrillation. You note that the evidence you heard shows that a fistula of this nature is a very rare, but known, risk of the ablation procedure. I was sorry to read of Ms Higham’s death and wish to extend my sincere sympathies to her family. You raise the following concerns: The ablation procedure for atrial fibrillation is becoming more widespread (an increase of around 20-30% has been seen in recent years). The development of an atrial-oesophageal fistula is a very rare, but known, risk of the ablation procedure (developing in around 0.01-0.2% of cases of percutaneous ablation and around 1-1.5% of cases of surgical ablation). If an atrial-oesophageal fistula does develop, it has a very high mortality rate (reported to be 67-100%). According to the literature there are no clear predictors of mortality from an atrial-oesophageal fistula, but early diagnosis, prompt surgical intervention and prolonged antibiotic therapy may be crucial for survival. Diagnosing an atrial-oesophageal fistula can be difficult, especially in an acute medical setting, given its range of non-specific symptoms and duration of onset, and the lack of awareness within the wider medical profession of such a fistula being a risk of the ablation procedure. My officials initially contacted the Royal College of Surgeons (RCS) about this case and were advised to consult the Society for Cardiothoracic Surgery (SCTS) and the British Cardiovascular Society (BCS), as your concern relates to a specific type of procedure. The SCTS confirmed that atrial-oesophageal fistula is a very rare complication of a cardiology procedure, which may present to upper gastrointestinal surgeons and, less often, thoracic surgeons. The SCTS suggested that both cardiologists and electro-physiologists, through the BCS, were best placed to respond to your concerns and suggested that BCS could prepare a letter to be circulated to the upper gastrointestinal surgeons, thoracic surgeons and cardiac surgeons. My officials have contacted the BCS about this suggestion and I understand that BCS are considering this proposal. Consideration includes the merits of circulating a letter to relevant surgeons, as the SCTS suggested. A copy of your letter and our response will be sent to the BCS. I trust they will take the opportunity to respond to you directly about this issue. You may of course wish to consider writing to the BCS, as the appropriate specialty organisation, yourself with your concerns. A copy of your letter and our response will also be sent to the RCS for their information. I hope that this response is helpful and I am grateful to you for bringing the circumstances of Ms Higham’s death to my attention. DRDAN POULTER
€ Public Health England — Protecting and improving the nation’s health Public Accountability Unit T +44 (0)20 7654 8000 Public Health England Wellington House www.gov.uk/phe 133-155 Wellington House SE1 8UG Clerk to HM Coroner Southwark Coroner's Court 1 Tennis Street SE17YD 22 December 2014 Our Ref: 141106122 RE: Prevent Future Deaths report touching the death of Mrs Sarah Higham Thank you for your letter of 6 November to Duncan Selbie regarding the circumstances of _Mrs Higham’s death. | have been asked to reply on Mr Selbie’s behalf. While | was sorry to read.of Mrs Higham’s death, this case is not something that Public Health England can directly assist with. However, | understand that you have written to the Department of Health, who will contact appropriate bodies on your behaif, such as the British Cardiology Society. The Department will be in touch with you in due course to inform you of the actions to be taken. | am sorry that | am unable to be of direct assistance on this occasion. Yours sincerely, Correspondence and Public Enquiries Officer Public Health England
See every Prevention of Future Deaths report matching Hospital Death (Clinical Procedures and medical management) related deaths, and how often a new one appears.
What would an alert for this have sent me? Search the full text
Free to try — the preview shows the real matches and how many arrived in the last 12 months. Your first email alert is free.
These reports are published by the Chief Coroner's office at judiciary.uk and are © Crown copyright. The text here is reproduced from the published PDF so it can be searched. If something on this page is wrong, or you are a person named in it and want it reviewed, email drcjar@gmail.com and we will act promptly.